Diversified Consumer Services
Company Overview of Johns Hopkins University
Johns Hopkins University is an educational institution offering undergraduate, graduate, part-time, summer, and distance education programs. The school of the university includes Krieger School of Arts and Sciences, Whiting School of Engineering, School of Professional Studies in Business and Education, School of Medicine, School of Nursing, Bloomberg School of Public Health, Nitze School of Advanced International Studies, The Peabody Institute, and Applied Physics Laboratory. Johns Hopkins University was established in 1876 and is based in Baltimore, Maryland. The university has endowment assets worth $2608.5 millions.
3400 North Charles Street
Baltimore, MD 21218-2683
Founded in 1876
Key Executives for Johns Hopkins University
Senior Associate Dean for Finance & Administration and Senior Associate Dean for Krieger School of Arts & Sciences
Executive Director of Communications and Public Affairs
Vice President of Communications and Public Affairs
Compensation as of Fiscal Year 2014.
Johns Hopkins University Key Developments
Bayer HealthCare and Johns Hopkins University Collaborate to Develop New Ophthalmic Therapies
Jun 16 15
Bayer HealthCare and The Johns Hopkins University in Baltimore have entered into a five-year collaboration agreement to jointly develop new ophthalmic therapies targeting retinal diseases. The partners will jointly work on the discovery and development of innovative drugs for the treatment of serious back-of-the-eye diseases that affect many people worldwide, including age-related macular degeneration (AMD), diabetic macular edema (DME), geographic atrophy, Stargardt's disease, and retinal vein occlusion (RVO). The goal of the strategic research alliance is to accelerate the translation of innovative approaches from the laboratory to the clinic, ultimately offering patients new treatment options for several retinal diseases. Under the agreement, Bayer and the Wilmer Eye Institute of Johns Hopkins will jointly conduct research activities evaluating new targets and disease mechanisms, drug delivery technologies, and biomarkers for back-of-the-eye diseases with high unmet medical need. Both parties will contribute personnel and infrastructure to address important scientific questions. Bayer will have an option for the exclusive use of the collaboration results. Financial terms of the agreement were not disclosed.
Johns Hopkins Medicine Appoints Robert A. Kasdin as Senior Vice President and Chief Operating Officer
May 13 15
Johns Hopkins Medicine announced the appointment of Robert A. Kasdin to the newly created role of senior vice president and chief operating officer. Kasdin comes to Johns Hopkins Medicine from Columbia University, where he has been senior executive vice president since 2002. He starts on July 1, 2015. As Johns Hopkins Medicine's first senior vice president and chief operating officer, Kasdin will partner with leadership to drive organization-wide change within a rapidly evolving environment. He will be responsible for overall operations, including strategic direction, administration of existing programs and development of new initiatives to ensure that Johns Hopkins Medicine's strategic imperatives are achieved or exceeded.
Johns Hopkins University Presents at IFC’s 17th Annual Global Private Equity Conference, May-11-2015 02:30 PM
May 8 15
Johns Hopkins University Presents at IFC’s 17th Annual Global Private Equity Conference, May-11-2015 02:30 PM. Venue: The Ritz-Carlton, Washington, District Of Columbia, United States. Speakers: Roger Leeds, Professor, Johns Hopkins University and Founding Chairman, EMPEA.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|